Skip to main content
Professional Technical IVT

PD-L1 expression

Pronunciation: P-D-L-one

Also written as: PD-L1 — Programmed Death-Ligand 1

The level of programmed death-ligand 1 protein on tumor cells, used to predict response to immunotherapy.

Full Definition

PD-L1 expression is measured by immunohistochemistry and reported as a tumor proportion score (TPS), representing the percentage of viable tumor cells showing membrane staining. High PD-L1 expression (typically ≥50% TPS) correlates with better response to PD-1/PD-L1 inhibitors like pembrolizumab. Different antibodies and scoring systems exist, making standardization important for treatment decisions.

Usage

Usage note: Always hyphenate PD-L1. Use 'expression' not 'positivity' for professional accuracy.

In Context

  • "PD-L1 expression was 60% by tumor proportion score." — Pathology report
  • "High PD-L1 expression supports first-line pembrolizumab monotherapy." — Treatment recommendation

Also known as

PD-L1 status programmed death-ligand 1 expression

Contrasted with

PD-L1 negative

Don't confuse with

PD-1 expression PDL1

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON